Information Journal Paper
APA:
Copy. (2019). Safety profile of baricitinib in patients with active rheumatoid arthritis with over 2 years’,median time in treatment. JOURNAL OF RHEUMATOLOGY, 46(1), 0-0. SID. https://sid.ir/paper/1012472/en
Vancouver:
Copy. Safety profile of baricitinib in patients with active rheumatoid arthritis with over 2 years’,median time in treatment. JOURNAL OF RHEUMATOLOGY[Internet]. 2019;46(1):0-0. Available from: https://sid.ir/paper/1012472/en
IEEE:
Copy, “Safety profile of baricitinib in patients with active rheumatoid arthritis with over 2 years’,median time in treatment,” JOURNAL OF RHEUMATOLOGY, vol. 46, no. 1, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/1012472/en